StockNews.com began coverage on shares of Lipocine (NASDAQ:LPCN – Free Report) in a report published on Wednesday morning. The brokerage issued a buy rating on the specialty pharmaceutical company’s stock. Lipocine Stock Down 6.1 % Shares of NASDAQ LPCN opened at $3.22 on Wednesday. The business’s 50 day moving average is $4.31 and its two-hundred […]
StockNews.com assumed coverage on shares of Lipocine (NASDAQ:LPCN – Free Report) in a research note published on Tuesday. The brokerage issued a buy rating on the specialty pharmaceutical company’s stock. Lipocine Stock Down 4.0 % Shares of Lipocine stock opened at $3.64 on Tuesday. Lipocine has a 52 week low of $3.30 and a 52 […]
EP Wealth Advisors LLC purchased a new position in Lipocine Inc. (NASDAQ:LPCN – Free Report) in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 66,983 shares of the specialty pharmaceutical company’s stock, valued at approximately $13,395,000. A number of other institutional investors have […]
StockNews.com began coverage on shares of Lipocine (NASDAQ:LPCN – Free Report) in a research note issued to investors on Monday morning. The firm issued a buy rating on the specialty pharmaceutical company’s stock. Lipocine Trading Down 4.5 % Shares of Lipocine stock opened at $3.65 on Monday. Lipocine has a 12 month low of $3.30 […]
StockNews.com began coverage on shares of Lipocine (NASDAQ:LPCN – Free Report) in a report issued on Monday morning. The firm issued a buy rating on the specialty pharmaceutical company’s stock. Lipocine Trading Down 4.3 % Shares of NASDAQ LPCN opened at $3.82 on Monday. Lipocine has a twelve month low of $3.30 and a twelve […]